A Curated Platform of Equity & Options Market Intelligence
Select Page

ALT

Search by
TICKER SYMBOL

Altimmune Inc

Sector: Manufacturing
Industry: Pharmaceutical Preparation Manufacturing

4.32

0.13

(3.103%)

Volume:

3,669,171

52 week range:

3.83 - 23.49

Market Cap:

212.885M

Company Description:

Altimmune is a clinical stage biopharmaceutical company focused on developing intranasal vaccines, immune modulating therapies and treatments for liver disease. Its diverse pipeline includes proprietary intranasal vaccines for COVID-19 (AdCOVID™), anthrax (NasoShield™) and influenza (NasoVAX™); an intranasal immune modulating therapeutic for COVID-19 (T-COVID™); and next generation peptide therapeutics for NASH (ALT-801) and chronic hepatitis B (HepTcell™).